substance p has been researched along with Epilepsy in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, G; Huang, Z; Li, G; Li, X; Zhang, K | 1 |
| Kovac, S; Walker, MC | 1 |
| Hwang, IK; Jung, JY; Kang, TC; Kim, DS; Seo, JH; Won, MH; Yoo, KY | 1 |
| Buzsáki, G; Doyle, WK; Freund, TF; Maglóczky, Z; Shigemoto, R; Tóth, K; Urbán, Z; Wittner, L | 1 |
| Woodbury, DM | 1 |
| Krieger, DT; Martin, JB | 1 |
| Beal, MF; Landis, DM; Marshall, PE; Martin, JB; Sagar, SM | 1 |
| Bouthillier, A; Nguyen, TD; Thorin, E | 1 |
| Cody, C; Jones, RS; Maubach, KA | 1 |
| Ruan, X; Wei, Y; Zhu, C; Zou, X | 1 |
| Martin, JL; Sloviter, RS | 1 |
| Albe-Fessard, D; Iwayama, K; Kurihara, M; Mori, K; Niwa, M; Tasker, RR; Yamashiro, K | 1 |
3 review(s) available for substance p and Epilepsy
| Article | Year |
|---|---|
Substance P Regulation in Epilepsy.
Topics: Brain; Epilepsy; Humans; Receptors, Neurokinin-1; Signal Transduction; Substance P | 2018 |
Neuropeptides in epilepsy.
Topics: Animals; Dynorphins; Epilepsy; Galanin; Ghrelin; Humans; Mice; Neuropeptide Y; Neuropeptides; Rats; Somatostatin; Substance P | 2013 |
Implications of neuropeptides in neurological diseases.
Topics: Alzheimer Disease; Animals; Brain; Cholecystokinin; Choline O-Acetyltransferase; Endorphins; Epilepsy; Forecasting; Histocytochemistry; Humans; Huntington Disease; Migraine Disorders; Nerve Tissue Proteins; Nervous System Diseases; Pain; Parkinson Disease; Radioimmunoassay; Somatostatin; Substance P; Thyrotropin-Releasing Hormone; Tissue Distribution; Vasopressins | 1984 |
9 other study(ies) available for substance p and Epilepsy
| Article | Year |
|---|---|
Elevated substance P (NK-1) receptor immunoreactivity in the cerebellum of seizure prone gerbil.
Topics: Animals; Antibodies; Cerebellar Nuclei; Corpus Striatum; Epilepsy; Gerbillinae; Immunohistochemistry; Purkinje Cells; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P | 2005 |
Morphology and synaptic input of substance P receptor-immunoreactive interneurons in control and epileptic human hippocampus.
Topics: Adult; Aged; Cell Count; Dendrites; Epilepsy; Female; Hippocampus; Humans; Immunohistochemistry; Interneurons; Male; Microscopy, Immunoelectron; Middle Aged; Nerve Tissue Proteins; Postmortem Changes; Substance P; Synapses | 2007 |
Convulsant drugs: mechanisms of action.
Topics: Amino Acids; Barbiturates; Biological Transport, Active; Brain; Cholinesterase Inhibitors; Convulsants; Epilepsy; gamma-Aminobutyric Acid; Glutamates; Glycine; Humans; Neurons; Pentylenetetrazole; Substance P | 1980 |
Brain peptides (second of two parts).
Topics: Acupuncture Therapy; Animals; Body Temperature Regulation; Brain; Brain Diseases; Cerebrospinal Fluid; Cholecystokinin; Endorphins; Enkephalins; Epilepsy; Feeding Behavior; Humans; Learning; Memory; Nervous System Diseases; Neurotransmitter Agents; Pain; Peptides; Pituitary Hormones; Substance P; Synaptic Transmission | 1981 |
Control of vascular tone by endogenous endothelin-1 in human pial arteries.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Arteries; Brain Neoplasms; Cerebral Cortex; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Epilepsy; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxymetazoline; Peptides, Cyclic; Pia Mater; Potassium Channel Blockers; Serotonin; Substance P; Tetraethylammonium; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Tachykinins may modify spontaneous epileptiform activity in the rat entorhinal cortex in vitro by activating GABAergic inhibition.
Topics: Animals; Baclofen; Bicuculline; Entorhinal Cortex; Epilepsy; Evoked Potentials; In Vitro Techniques; Male; Membrane Potentials; Neurokinin A; Neurokinin B; Neurons; Peptide Fragments; Phosphinic Acids; Propanolamines; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Reaction Time; Receptors, GABA-A; Receptors, GABA-B; Substance P; Synapses; Tachykinins | 1998 |
[Alterations of substance P-immune reaction positive neurons of cerebral tissues in epileptic rats].
Topics: Amygdala; Animals; Calcium Channel Blockers; Cerebral Cortex; Epilepsy; Female; Hippocampus; Male; Neurons; Nimodipine; Penicillins; Rats; Rats, Wistar; Substance P | 1997 |
Focal inhibitory interneuron loss and principal cell hyperexcitability in the rat hippocampus after microinjection of a neurotoxic conjugate of saporin and a peptidase-resistant analog of Substance P.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Death; Epilepsy; Glial Fibrillary Acidic Protein; Hippocampus; Immunohistochemistry; Immunotoxins; Interneurons; Male; Membrane Potentials; Mossy Fibers, Hippocampal; N-Glycosyl Hydrolases; Nerve Net; Neural Inhibition; Neuronal Plasticity; Neurotoxins; Peptide Fragments; Peptide Hydrolases; Plant Proteins; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Ribosome Inactivating Proteins, Type 1; Saporins; Substance P | 2001 |
Neurones with epileptiform discharge in the central nervous system and chronic pain. Experimental and clinical investigations.
Topics: Animals; Chronic Disease; Cortical Spreading Depression; Electroencephalography; Epilepsy; Evoked Potentials; Humans; Locus Coeruleus; Neurons; Pain; Raphe Nuclei; Rats; Somatosensory Cortex; Substance P; Thalamic Nuclei | 1991 |